HOME
• lipitor website
• lipitor cause vertigo
• lipitor side effects sleep
• lipitor and peripheral neuropathy

plavix and lipitor

You may also report side effects at http://www.fda.gov/medwatch. Do not drive or perform other possibly unsafe tasks until you know how you react to it. It is used along with an appropriate diet. These are not all the side effects of Lipitor. Before using Lipitor: Some medical conditions may interact with Lipitor. What is Cholesterol? Cholesterol and triglycerides are fats that are made plavix and lipitor your body. 6.3 Pediatric Patients (ages 10–17 years) In a 26-week controlled study in boys and postmenarchal girls (n=140, 31% female; 92% Caucasians, 1.6% Blacks, 1.6% Asians, 4.8% other), the safety and tolerability profile of Lipitor 10 plavix and lipitor 20 mg daily was generally similar to that plavix and lipitor placebo . Skip the missed dose if your next dose is less than 12 hours away.

Go To...

• lipitor pros and cons
• lipitor research
• lipitor alternative drugs
• lipitor glucose
• cost of lipitor 10mg

plavix and lipitor

Do not change your dose or stop Lipitor without talking to your doctor. If you have any of these other conditions, you plavix and lipitor need to adjust your Lipitor dose or have special tests: history of liver disease; history of kidney disease; diabetes; a thyroid disorder; or if you drink more than 2 alcoholic beverages daily. 5.2 Liver Dysfunction Statins, like some other lipid-lowering therapies, have been associated with biochemical abnormalities of liver function. Most effects tended to be mild and transient. If you have any of these other conditions, you may need to adjust your Lipitor dose or have special tests: history of liver disease; history of plavix and lipitor disease; diabetes; a thyroid disorder; or if you drink more than 2 alcoholic beverages daily. Nonclinical Toxicology 13.1 Carcinogenesis, Mutagenesis, Impairment of Fertility In a 2-year carcinogenicity study in rats at dose levels of 10, 30, and 100 mg/kg/day, 2 rare tumors were found in muscle in high-dose females: in one, there was a rhabdomyosarcoma and, in another, there was a fibrosarcoma. The proportions of subjects who experienced CV or non-CV death were similar for the Lipitor 80 mg group and the simvastatin 20–40 mg group. Version: 12.01. Such patients merit closer monitoring for skeletal muscle effects. If you have any of these other conditions, you may need to adjust your Lipitor dose or have special tests: history of liver disease; history of kidney disease; diabetes; a thyroid disorder; or if you drink more than 2 alcoholic beverages daily. In addition, at least one case of polyneuropathy attributed to atorvastatin use has also been reported. Multum information has been compiled plavix and lipitor plavix and lipitor by healthcare practitioners and consumers in the United States and therefore Multum does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. TABLE 7. 17.1 Muscle Pain All patients starting therapy with Lipitor should be advised of the risk of myopathy and told to report promptly any unexplained muscle pain, tenderness, or weakness. 12.2 Pharmacodynamics Lipitor, as well as some of its metabolites, are pharmacologically active in humans. However, LDL-C reduction is the same regardless of the time of day of drug administration . The empirical formula of atorvastatin calcium is (C33H34 FN2O5)2Ca•3H2O and its molecular weight is 1209.42. Myopathy should plavix and lipitor considered in any patient with diffuse myalgias, muscle tenderness or weakness, and/or marked elevation plavix and lipitor CPK. 82 deaths in the placebo group (HR 0.73, p=0.059). Lipitor is usually taken once a day, with or without food. Rx Only Manufactured by Pfizer Ireland Pharmaceuticals Dublin, Ireland LAB-0348-4.0 June 2009 PRINCIPAL DISPLAY PANEL LipitorŽ                  10 (atorvastatin calcium) tablets 10 mg LipitorŽ                  20 (atorvastatin calcium) tablets 20 mg LipitorŽ                  40 (atorvastatin calcium) tablets 40 mg LipitorŽ                  plavix and lipitor (atorvastatin calcium) tablets 80 plavix and lipitor Lipitor  atorvastatin calcium  tablet, film coated Product Information Product Type HUMAN PRESCRIPTION DRUG NDC Product Code (Source) 54868-4229 (0071-0157) Route of Administration ORAL DEA Schedule      Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength ATORVASTATIN CALCIUM (ATORVASTATIN) ATORVASTATIN CALCIUM 40 mg Inactive Ingredients Ingredient Name Strength CALCIUM CARBONATE   CANDELILLA WAX   CROSCARMELLOSE SODIUM   HYDROXYPROPYL CELLULOSE   LACTOSE MONOHYDRATE plavix and lipitor MAGNESIUM STEARATE   CELLULOSE, MICROCRYSTALLINE   HYPROMELLOSE   POLYETHYLENE GLYCOL   plavix and lipitor   TITANIUM DIOXIDE   POLYSORBATE 80   Product Characteristics Color white Score no score Shape OVAL (elliptical) Size 15mm Flavor Imprint Code PD;157;40 Contains      Packaging # NDC Package Description Multilevel plavix and lipitor 1 54868-4229-0 30 TABLET In 1 BOTTLE None 2 54868-4229-1 90 TABLET In 1 BOTTLE None 3 54868-4229-2 15 TABLET In 1 BOTTLE None 4 54868-4229-3 45 TABLET In 1 BOTTLE None Marketing plavix and lipitor Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date NDA NDA020702 07/06/2000 Lipitor  atorvastatin calcium  tablet, film coated Product Information Product Type HUMAN PRESCRIPTION DRUG NDC Product Code (Source) 54868-3946 (0071-0156) Route of Administration ORAL DEA Schedule      Active Ingredient/Active Moiety Ingredient Name Basis plavix and lipitor Strength Strength ATORVASTATIN CALCIUM (ATORVASTATIN) ATORVASTATIN CALCIUM 20 mg Inactive Ingredients Ingredient Name Strength CALCIUM CARBONATE   CANDELILLA WAX   CROSCARMELLOSE SODIUM   HYDROXYPROPYL CELLULOSE   LACTOSE MONOHYDRATE   MAGNESIUM STEARATE   CELLULOSE, MICROCRYSTALLINE   plavix and lipitor   POLYETHYLENE GLYCOL   TALC   TITANIUM DIOXIDE   POLYSORBATE 80   Product Characteristics Color white plavix and lipitor no score Shape OVAL (elliptical) Size 12mm Flavor Imprint Code PD;156;20 plavix and lipitor      Packaging # NDC Package Description Multilevel Packaging 1 54868-3946-0 30 TABLET plavix and lipitor BOTTLE None 2 54868-3946-1 15 TABLET In 1 BOTTLE None 3 54868-3946-2 90 TABLET In 1 BOTTLE None 4 54868-3946-3 60 TABLET In 1 BOTTLE None 5 54868-3946-4 45 TABLET In 1 BOTTLE None Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date NDA NDA020702 03/12/2004 Lipitor  atorvastatin calcium  tablet, film coated Product Information Product Type HUMAN PRESCRIPTION DRUG NDC Product Code (Source) 54868-4934 (0071-0158) Route of Administration ORAL DEA Schedule      Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength ATORVASTATIN CALCIUM (ATORVASTATIN) ATORVASTATIN CALCIUM 80 mg Inactive Ingredients Ingredient Name Strength CALCIUM CARBONATE   CANDELILLA WAX   CROSCARMELLOSE SODIUM   HYDROXYPROPYL CELLULOSE   LACTOSE MONOHYDRATE   MAGNESIUM STEARATE   CELLULOSE, MICROCRYSTALLINE   HYPROMELLOSE   POLYETHYLENE GLYCOL   TALC   TITANIUM DIOXIDE   POLYSORBATE 80   Product Characteristics Color white Score no score Shape OVAL (elliptical) Size 19mm Flavor Imprint Code PD;158;80 Contains      Packaging # NDC Package Description Multilevel Packaging 1 54868-4934-0 30 TABLET In 1 BOTTLE None 2 54868-4934-1 plavix and lipitor In 1 BOTTLE plavix and lipitor Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date NDA NDA020702 01/11/2006 Lipitor  atorvastatin calcium  tablet, film coated Product Information Product Type HUMAN PRESCRIPTION DRUG NDC Product Code (Source) 54868-3934 (0071-0155) Route of Administration ORAL DEA Schedule      Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength ATORVASTATIN CALCIUM (ATORVASTATIN) ATORVASTATIN plavix and lipitor 10 mg Inactive Ingredients Ingredient Name Strength CALCIUM CARBONATE   CANDELILLA WAX   CROSCARMELLOSE SODIUM   HYDROXYPROPYL CELLULOSE   LACTOSE MONOHYDRATE   MAGNESIUM STEARATE   CELLULOSE, MICROCRYSTALLINE   HYPROMELLOSE   POLYETHYLENE GLYCOL   TALC   TITANIUM DIOXIDE   POLYSORBATE 80   Product Characteristics Color white Score no score Shape OVAL (elliptical) Size 10mm Flavor Imprint Code PD;155;10 Contains      Packaging # NDC Package Description Multilevel Packaging 1 54868-3934-3 10 TABLET In 1 BOTTLE None 2 54868-3934-0 30 TABLET In 1 BOTTLE None 3 54868-3934-4 45 TABLET In 1 BOTTLE None 4 54868-3934-2 60 TABLET In 1 BOTTLE None 5 54868-3934-1 90 TABLET In 1 BOTTLE None Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date NDA NDA020702 05/05/1997 Labeler - Physicians Total Care, Inc (194123980) Revised: 08/2009Physicians Total Care, Inc Lipitor Generic Name: Atorvastatin (a-TOR-va-STAT-in) Brand Name: Lipitor Lipitor is plavix and lipitor for: Lowering high cholesterol and triglycerides in certain patients. In a post-hoc analysis, Lipitor plavix and lipitor mg reduced the incidence of ischemic stroke (218/2365, 9.2% vs. Tell your doctor if you have trouble swallowing the pill You may need to stop using atorvastatin for a short time if you have: uncontrolled seizures; an electrolyte imbalance (such as high or low potassium levels in your blood); severely low blood pressure; a severe infection or illness; or surgery or a medical emergency. To be sure this medicine plavix and lipitor helping your condition and is not causing harmful effects, your blood will need to be tested often. Overdosage Although no specific information about Lipitor overdose is available, any medication taken in excess can have serious consequences. The maximum recommended daily dose is 80 milligrams. Furthermore, the independent plavix and lipitor of raising HDL or lowering plavix and lipitor on the risk of coronary and cardiovascular morbidity and mortality has not been determined. Keep Lipitor out of the reach of children and away from pets. Avoid becoming pregnant while you are taking it. Because these reactions are reported voluntarily from a population of plavix and lipitor size, it is not always possible to plavix and lipitor estimate their frequency or establish a causal relationship to drug exposure. NDC 54868-3934-3 bottles of 10 NDC 54868-3934-0 bottles of 30 NDC 54868-3934-4 bottles of 45 NDC 54868-3934-2 bottles of 60 NDC 54868-3934-1 bottles of 90 20 mg tablets: coded "PD 156" on one side and "20" on the other.